Full Text | PDF

Share on tweeters Share on facebook Share on linkedin Share on googleplus

Int J Med Sci 2022; 19(4):695-700. doi:10.7150/ijms.70916 This issue Cite

Research Paper

Efficacy and safety of endovenous laser ablation with the 1470 nm diode laser using a novel optical probe

Karsten Hartmann, MD1*, Patrick Gholam, MD2*, Carmen Dietrich, MD2, Christine Fink, MD2✉

1. Venenzentrum Freiburg, Zähringer Str. 14, 79108, Freiburg, Germany.
2. Department of Dermatology, University of Heidelberg, Heidelberg, Germany.
* Both authors contributed equally

✉ Corresponding author: PD Dr. med. Christine Fink, Department of Dermatology, University of Heidelberg Im Neuenheimer Feld 440, 69120 Heidelberg, Germany. christine.finkuni-heidelberg.de. Phone: +49-6221-56-39554, Fax: +49-6221-56-8510

Citation:
Hartmann K, Gholam P, Dietrich C, Fink C. Efficacy and safety of endovenous laser ablation with the 1470 nm diode laser using a novel optical probe. Int J Med Sci 2022; 19(4):695-700. doi:10.7150/ijms.70916. https://www.medsci.org/v19p0695.htm
Other styles

File import instruction

Abstract

Graphic abstract

Objectives: Outcome assessment of a novel optical fiber probe for the 1470 nm diode laser under real-world conditions.

Methods: Prospective clinical pilot study in 10 patients undergoing endovenous laser ablation with a follow-up period of 1 year. Primary endpoints were efficacy and safety. Secondary endpoints include, inter alia, quality of life and patient satisfaction.

Results: After a follow-up period of 1 year all treated vein segments were still occluded. Only mild and short-term side effects (hematoma, ecchymosis and hyperpigmentation) were observed. No intake of pain medication was needed and a quick return to normal activity was documented (0.9 days). Clinical hallmarks of the venous disease (VCSS) improved significantly (p= .003). All patients were very satisfied with the treatment and quality of life (AVVQ) was significantly improved after the procedure (p=.008).

Conclusions: The study demonstrates that the endoluminal treatment with the novel fiber probe is highly effective and safe.

Keywords: Varicose veins, EVLA, Laser ablation, Efficacy, Safety, Outcome

Citation styles

APA
Hartmann, K., Gholam, P., Dietrich, C., Fink, C. (2022). Efficacy and safety of endovenous laser ablation with the 1470 nm diode laser using a novel optical probe. International Journal of Medical Sciences, 19(4), 695-700. https://doi.org/10.7150/ijms.70916.

ACS
Hartmann, K.; Gholam, P.; Dietrich, C.; Fink, C. Efficacy and safety of endovenous laser ablation with the 1470 nm diode laser using a novel optical probe. Int. J. Med. Sci. 2022, 19 (4), 695-700. DOI: 10.7150/ijms.70916.

NLM
Hartmann K, Gholam P, Dietrich C, Fink C. Efficacy and safety of endovenous laser ablation with the 1470 nm diode laser using a novel optical probe. Int J Med Sci 2022; 19(4):695-700. doi:10.7150/ijms.70916. https://www.medsci.org/v19p0695.htm

CSE
Hartmann K, Gholam P, Dietrich C, Fink C. 2022. Efficacy and safety of endovenous laser ablation with the 1470 nm diode laser using a novel optical probe. Int J Med Sci. 19(4):695-700.

This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions.
Popup Image

©2024 Ivyspring International Publisher. Terms of use